Thomas Andrew Suter is named as a lobbyist on federal disclosure filings for 1 client through Novartis. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Trade (domestic/foreign), Taxation/Internal Revenue Code and Copyright/Patent/Trademark.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| NOVARTIS | NOVARTIS | Q3 2026 | Trade (domestic/foreign), Budget/Appropriations, Taxation/Internal Revenue Code |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Thomas Andrew Suter. See the Capitol Clarity rankings and method.